Wednesday, 28 September 2022
11:00am - 12:00pm EDT / 5:00pm - 6:00pm CEST
Join us for a unique panel discussion with Eli Lilly and Company’s Legal and Library teams on how they partner to accelerate the innovation of new medicines, improve patient outcomes, and promote global copyright compliance.
Lilly strives to not only create high-quality medicines, but also ensure that the benefits and risks of medications are continuously monitored and well-understood by regulators, health care professionals and patients.
Whether R&D teams researching new discoveries, Pharmacovigilance teams monitoring adverse reactions, Regulatory teams reporting to health agencies, or Medical Communications teams working with doctors to promote patient safety, they rely on access to the latest information and scientific literature to support that mission.
Hear how they are also committed to making sure that employees are accessing and reusing content compliantly. Regardless of your industry, this session will serve as a model for anyone involved with managing information and copyright throughout the organization.
Featuring:
 |
 |
 |
 |
|
Christina Bennett McNew, |
John Rudolph, Ph.D., LL.B. |
Bruce Longbottom |
Stephen Casbeer, |